Rankings
▼
Calendar
VRCA Q2 2018 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$59M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-9.24
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$105M
Total Liabilities
$3M
Stockholders' Equity
$102M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$6M
-$1M
-458.2%
Net Income
-$6M
-$1M
-444.2%
← FY 2018
All Quarters
Q3 2018 →